Granville A Ungerleider has over thirty years of investment banking and strategic advisory experience. He has initiated, led, and implemented a broad array of initiatives with an emphasis on financial restructurings, mergers & acquisitions, divestitures, private equity investments, and public offerings of equity & debt securities including taxable and tax-exempt financings. He has successfully orchestrated equity and debt offering in trying economic environments across a diverse set of industry sectors and geographic.
Mr. Ungerleider is also currently the CEO and Managing Member of Whitemarsh Capital Advisors LLC, a member of FINRA and President, Managing Member, and Member of the Executive Committee of Ellington Healthcare Asset Management LLC, the management company of Ellington Healthcare Partners I, L.P., a venture capital fund specializing in early-stage investments in BioPharma. In addition, he is also a Managing Member of NSIP LLC, the General Partner of Ellington Healthcare Partners I, L.P.
Mr. Ungerleider successfully organized investors and operators into a joint partnership that was the successful bidder for an extensive portfolio of Broadcast Television Stations from a bankrupt estate. He designs and structures municipal finance programs domestically and internationally, including the first private/ municipal joint ventures to construct parking garages in Russia. Mr. Ungerleider advised an insurance holding company client on strategies leading to successful multiple acquisitions and arranged equity infusions required to consummate the transactions.
He was an early pioneer in the use of rated debt in Real Estate Finance, and the principal developer of highly successful municipal leasing and parking garage finance programs, higher education finance initiatives, mortgage-backed bond issues, the original community cable partnerships which became the foundation of Comcast, and the successful public offering of the first two casinos in Atlantic City.
Mr. Ungerleider holds FINRA series 24, 7, 53, 63, 79, and 99 licenses.
Dr. Anthony J. Tether was Director of the Defense Advanced Research Projects Agency (DARPA) from 2001 to his retirement in 2009. DARPA is the principal Agency within the Department of Defense for research, development, and demonstration of concepts, devices, and systems that provide highly advanced new technology capabilities. As Director, Dr. Tether was responsible for management of the Agency's projects for high-payoff, innovative research, and development. During his tenure, DARPA made grants of close to $25 billion.
Dr. Tether was the Founder of The Sequoia Group (TSG), which serves government and industrial clients. The Sequoia Group provides program management and strategy development services to government and industry. He is on several Advisory and Corporate Boards and is a Distinguished Fellow with the Council on Competitiveness located in Washington DC.
He was Vice President of Science Applications International Corporation's (SAIC) Advanced Technology Sector, and then Vice President and General Manager for Range Systems at SAIC. Prior to this, he spent six years as Vice President for Technology and Advanced Development at Ford Aerospace Corp., acquired by Loral Corporation during that period.
Dr. Tether held positions in the Department of Defense, serving as Director of DARPA's Strategic Technology Office, and as Director National Intelligence in the Office of the Secretary of Defense. He served as Vice President of Systems Control Inc., a company he helped start after receiving his Ph.D., where he applied estimation and control theory to military and commercial problems with particular concentration on development and specification of algorithms to perform real-time resource allocation and control.
Dr. Tether has served on Army, Navy and Defense Science Boards, and on the Office of National Drug Control Policy Research and Development Committee. He is a Senior Life Member of the Institute of Electrical and Electronics Engineers (IEEE). The Director Central Intelligence Bill Casey and the Secretary of Defense Casper Weinberger honored him with the National Intelligence Medal and the Department of Defense Civilian Meritorious Service Medal respectively. Secretary of Defense Robert Gates honored him with the Department of Defense Outstanding Public Service Medal.
Dr. Tether received his Bachelor's of Electrical Engineering from Rensselaer Polytechnic Institute and his Master of Science and Ph.D. in Electrical Engineering from Stanford University.
Admiral Jay M. Cohen was the 20th Chief of Naval Research and was the former Navy Chief Technology Officer. He was responsible for the $2B+/year Navy and Marine Corps Science and Technology (S&T) Program (involving basic research to applied technology portfolios and contracting), He coordinated investments with other U.S. and international S&T providers to rapidly meet needs. Admiral Cohen was unanimously confirmed by the US Senate, he was sworn in as Under Secretary for Science & Technology at the Department of Homeland Security (responsible for DHS Research, Development, Test and Evaluation).
He was commissioned in 1968 upon graduation from the United States Naval Academy. He holds a joint Ocean Engineering degree from Massachusetts Institute of Technology and Woods Hole Oceanographic Institution and Master of Science in Marine Engineering and Naval Architecture from MIT.
His early Navy assignments included service on conventional and nuclear submarines. He commanded USS HYMAN G. RICKOVER (SSN 709). Following command, he served on the U.S. Atlantic Fleet as a senior member of the Nuclear Propulsion Examining Board, responsible for certifying the safe operation of nuclear-powered ships and crews.
In addition, he commanded the submarine tender USS L.Y. SPEAR (AS 36) (with a crew of 400 women and 800 men) including a deployment to the Persian Gulf in support of Operation DESERT STORM After Spear, he reported to the Secretary of the Navy as Deputy Chief of Navy Legislative Affairs. During this assignment, Cohen was responsible for supervising all Navy Congressional liaison and reported to the Joint Staff as Deputy Director for Operations responsible to the President and DoD leaders for strategic weapons release authority.
Since leaving the government, Rear Admiral Cohen serves on numerous corporate boards and is an independent consultant for science and technology in support of domestic and international defense, homeland security/cybersecurity and energy issues/solutions. Additionally, he is on medical device and cancer treatment boards. For the past several years Cohen has served on a US National Science Foundation Advisory Panel and in 2018 at the request of the then Secretary of Defense, Gen. Mattis, USMC (ret.), Cohen participated in a SecDef directed effort to identify CRITICAL Defense base infrastructure and enhance base security and power resiliency and reliability with DoD and DoE.
Over a 35-year career, Dr. Gerald J. Elfenbein has become one of the leading international researchers in the fields of oncology, immunology and stem cell transplantation. Most recently, he has served as Professor of Medicine at Boston University School of Medicine in Massachusetts, Director of the Roger Williams Cancer Center (Providence, RI) and as the Director of the Blood and Marrow Transplant Program at Roger Williams.
During his distinguished career, Dr. Elfenbein has served in positions with several prestigious national institutions. At the H. Lee Moffitt Cancer Center and Research Institute in Tampa, FL, he was the Director of the Bone Marrow Transplant Program and Chief of its Bone Marrow Transplant Service. Concurrently with his service with the Moffitt Center, he was a Professor of Internal Medicine and Director, Division of Bone Marrow Transplantation, at the University of South Florida College of Medicine.
Dr. Elfenbein’s research and practice have focused on adult and pediatric blood and marrow autologous and allogeneic stem cell transplantation. His research also included work in the areas of leukemias, lymphomas, myeloma and breast cancer. He has authored or co-authored over 150 articles for such prestigious publications as The New England Journal of Medicine, the Journal of Clinical Oncology, The Journal of Immunology, The Journal of Experimental Medicine, Blood, the Journal of Radiation Oncology, the American Journal of Pediatric Oncology. In addition, Dr. Elfenbein has authored or co-authored over 50 monographs or book sections in scholarly publications.
Dr. Elfenbein has been honored by such organizations the American Society of Clinical Oncology, the American College of Physicians, the International Who’s Who of Medicine, the American Board of Internal Medicine, the European Group for Blood and Marrow Transplantation, the Guide to America’s Top Oncologists and the International Society for Experimental Hematology.
Dr. Elfenbein graduated summa cum laude from Harvard College and received his M.D. from the Johns Hopkins University’s School of Medicine. During the Vietnam War, he was a surgeon in the U.S. Public Health Service and a Research Associate with the National Institute of Allergy and Infectious Diseases at the National Institutes of Health (Bethesda, MD).
Professor Brian Glenville was the pioneer of beating heart surgery. His surgical career was international, both extensively operating and lecturing abroad as one of the pioneers of beating heart surgery and at one time had built up amongst the world’s largest series of cases. He started his business career by advising London City Financial institutions like Morgan Grenfell and Deutsche Bank on trends in new drugs and specific cardiovascular heart failure drugs in development. He became medical director of Cardionetics Ltd. an EKG self-analysis consumer device company at the behest of the Goldman family (Sage Software/ BATM Advanced Communication). This company was successfully sold to a privately held manufacturing company.
He served as the medical director of UV-Science and Maximyo. These two privately held companies develop and manufacture muscle stimulators for both the medical and cosmetic areas. He provided an effective interface between design and clinical use. IDr. Glenville was the medical director of Discover Medical, a company that developed a unique sleep apnoea mask. He ensured that the clinical trials were appropriate for both commercial and clinical needs. In 2012, he became Chairman of Azure PCR Ltd. a real-time PCR company. Azure PCR is a fast growing company with heavily patent protected technology for the analysis phase of in vitro diagnostics.
Dr. Glenville advised VC companies like Meditech Partners where he became a venture partner assessing specific companies that were investment targets. He was shown to have a good track record both positively in recommendations and also companies where the advice was not to proceed. Dr. Glenville was the keynote speaker at a UBS investment conference in Tel Aviv where he spoke on how business plans may fail to match reality.
Professor Glenville has an MD from London University, an honours BSc in Immunology, a Master’s degree in Surgery and higher specialization certification in cardiothoracic surgery both in the UK and in Israel. He also served on “European Union Initiatives” advising on artificial hearts, having performed the first successful bridge to transplant artificial heart in the UK.
Seth Gilbert is a senior professional with more than fifteen years of experience as an entrepreneur, an industry analyst, advisor, and executive in technology and venture capital.
Mr. Gilbert first honed his transactional experience on the deal teams of multiple venture financings (buy and sell side), initial public offerings and mergers and acquisitions at Wilson Sonsini Goodrich & Rosati. The next phase of his career was spent working in senior business development, strategy and corporate development roles at startups including 401Konnect and Privada. At Privada, as Director of Business Development, Mr. Gilbert was responsible for initiating key strategic partnerships and also co-inventor of a credit card anti-fraud initiative and strategy that became a principle part of the company's product offerings.
After several years working in venture transactions and startup operations, Mr. Gilbert made the natural migration to the investor side of the marketplace. He joined 3CV, a venture incubator focused on commercializing technologies developed at universities and major research facilities as a principal and Vice President of Business Development. He was responsible for evaluating investment opportunities, and providing consulting services (including financing strategy, product development and go-to-market planning) for a wide range of development-stage client companies.
He launched Metue.com. Metue, which was in name an acronym for Media Entertainment and Technology User Experience Mr. Gilbert grew Metue to reach several hundred thousand unique visitors per month. The audience sampling included regular repeat readers from Fortune 500 companies, global investment banks, top tier venture capital funds, Hollywood studios , record labels, and significant international news publications.
Mr. Gilbert is an expert in digital media. He is highly experienced in transactional due diligence and deal structuring. Mr. Gilbert specializes in consumer-facing digital media and technology companies and in bio-pharma. He is a graduate of Emory University.
Joseph D. Gonnelli is recognized real estate professional since 1980. He has extensive experienced in all facets of real estate development and finance. As the President of Rosewood Real Estate Enterprises, his developmental expertise won design awards in New Jersey for a world-class medical office project for Lourdes Health System a leading provider of medical services in New Jersey. This project developed on the site of a former supermarket that was abandoned by its owners. This property is now highest grossing income generators for the System.
Mr. Gonnelli as the Managing Partner of several real estate development partnerships successfully completed the following: designed, developed, financed, operated the largest privately held public assembly facility in the Philadelphia area, the South Jersey Expo Center; acquired multiple office and industrial parks during the FDIC auctions in the 1990s, including several vacant office buildings and by executing an aggressive leasing strategy resulting in full occupancy sold the portfolio to Brandywine Realty Trust, resulting in a multi-million dollar profit for the partners.
His additional accomplishments are developing and building a suburban office project for Dun and Bradstreet Corporation, completing it in less than eight months and obtaining preliminary and obtaining final site plan approvals in one township meeting. Mr. Gonnelli also assembled four different properties on two sides of a divided highway from separate owners in which he successfully negotiated appropriate easements and site control to establish a full traffic light intersection for the assembled properties thereby enhancing the value of all the acquired land. He accomplished this in 18 months without the use of straw parties and maintained the highest confidentiality.
Mr. Gonnelli is noted for solving challenging environmental issues. He successfully remediated a contaminated site adjacent to sensitive residential sites, in less than 14 months, obtaining unrestricted use permits from New Jersey Department of Environmental Protection.
He earned a BS in Chemistry at St. Joseph’s University and a MS in Pharmacology from the University of Pennsylvania and simultaneously completed the executive real estate program at the Wharton School. Mr. Gonnelli is licensed as a real estate professional in Florida and holds two insurance licenses
Richard Y. Fu has fifteen years of experience spanning two main industries, financial services and gaming/entertainment. After graduating from York University, he began his career with TD Waterhouse in Canada. Richard was responsible for the Integration of Green Line Investor Services and led the group’s efforts to develop both Brokerage and Asset Management businesses in the Asia Pacific Region. In this capacity, Richard led TD Waterhouse’s efforts in both corporate strategy and cross-border, multi-cultural marketing. In 1999, he transferred to the United States as a member of the Management Committee responsible for the entire Asia Pacific division, leading TD Waterhouse’s efforts across the brokerage spectrum from investment banking to trading. He became a prominent figure in both Retail and Institutional in the international Arena.
Mr. Fu joined E*Trade Financial to lead development of its Asia Pacific division and advise on strategic, acquisition, CRM, and new product development. During this period, he acted as an investment banker to E*Trade, analyzing different potential acquisitions. This experience enabled him to understand banking not only from the investor side, via his TD Waterhouse experience, but also from the client side. This unique dual perspective allows Mr Fu to appreciate the often competing perspectives and bridge the potential gaps and lead several successful equity transactions.
In 2005, Richard left the Brokerage industry to move to Harrah’s Entertainment, Inc. (now Caesars Entertainment Corporation) as Senior Corporate Director, responsible for the development and implementation of Harrah’s comprehensive multicultural strategies, including VIP strategy, capital investment, expansion, operational efficiently and effectiveness, CRM, brand marketing, direct marketing, mass media, public relation, market research. He engineered the initiative to attract ethnic customer which then lead to the company’s overall revenue doubled within the period. He has been recognized for his efforts as a recipient of the award for National Asian Pacific American Corporate Achievement. Richard has served as an advisor to Penn National Gaming Inc. and to European and Asian gaming entities.
Mr. Fu also holds the FINRA series 3, 7, 9, 10, 24, 79, & 63 licenses as well as many Canadian Securities Institute credentials.
Joseph M. Braunschek is a seasoned investment banking and finance company professional, having evaluated and analyzed hundreds of companies and financed well over $1 billion of debt, including municipal issues, hospital, and nursing home-related bonds, as well as direct real estate and asset-backed loans to the senior housing industry.
Mr. Braunschek began his career as a financial analyst with Van Kampen Merritt. In that capacity, he was responsible for modeling borrower cash flows, sizing bond issues, and identifying potential candidates for refinancing or restructuring. Mr. Braunschek also analyzed industry trends (particularly in hospitals and health care-related borrowers) and was instrumental in the development of the Merritt System, a computerized hospital analytical database which is still in use today. Moving to McDonald and Company, Mr. Braunschek’s scope expanded to include supervision of documentation and client contact, including direct sales and marketing efforts. These responsibilities increased through his employment at William E. Simon and Sons Municipal Securities Inc, A.H. Williams & Co. and J.G. Wentworth Securities.
When JG Wentworth was sold to DVI in 1997, Mr. Braunschek became a direct lender to the long-term care industry, a position he has held through his employment at a number of major credit companies, including GMAC Commercial Mortgage (now Capmark), CIT Group and GMAC ResCap. While at GMAC Commercial, Mr. Braunschek helped manage a portfolio of over $1.5 billion of long-term care and seniors housing mortgage loans as well as serving as interim chief credit officer for the Health Care division. At CIT he helped develop the healthcare division into an industry leader, serving as underwriter and portfolio manager on both the real estate and receivable-backed sectors.
Through his career, Mr. Braunschek has spoken at several industry conferences as well as serving on the board of Good Neighbor Care, an Oregon-based senior housing operator. Mr. Braunschek graduated cum laude from Temple University with a degree in business administration.
Dr. Kenneth E. Lehrer has been an Economic and Financial Services Consultant since 1980. He holds four (4) degrees from New YorkUniversity: Bachelor of Science (Finance), Master of Business Administration (Banking), Master of Arts (Economics) and a Doctorate in Urban Economics. After a career on the corporate staff of Bankers Trust Company (New York), Dr. Lehrer became a Manager for the Greek Shipper, Costas Lemos [dec'd]. Here, he assisted on projects in New York, Houston, Denver, Guam and in Europe.
Dr. Lehrer is experienced in many areas of - Economics, Finance, Economic Damage Analysis (including Business and Technology Losses), Banking, Business, ESOP and Non-Public Business Valuations, Securities, Healthcare, Fairness and Advisory Opinions, Intellectual Property Valuations, Real Estate and Corporate Finance. He has prepared institutional economic / finance reports, feasibility analysis, corporate business plans and provides litigation support (having been qualified in both State and Federal Courts) in the areas of - economics, real estate, banking, corporate and IP valuations, class actions, and finance. Dr. Lehrer served for approximately twenty years as an Adjunct Professor of Finance at the University of Houston, Graduate School of Business Administration and is presently an Adjunct Professor of Finance and Economics at the University of Phoenix. Dr. Lehrer is also a speaker at business, economic and real estate seminars.
Dr. Lehrer has served as Chairman of the Board of Directors for the Federal Home Loan Bank of Dallas as agent for the Federal Savings and Loan Insurance Corporation of - Acadia Savings and Loan Association, French Market Homestead Savings, Twin City Savings, First Savings of Louisiana. Presently, Dr. Lehrer is a Director of Aztec Oil and Gas, a publicly traded corporation.On a professional basis, Dr. Lehrer is a Texas State Certified General Real Estate Appraiser and is recognized by the National Association of Real Estate Appraisers. With his firm, he is a member of - National Association of Business Economists, American Academy of Economic and Financial Experts, American Law and Economics Association, Houston Business Economists, National Forensic Center, National Association of Forensic Economists, American Economic Association, North American Economics and Finance Association, Southern Economic Association, Western Economic Association and the Finance Club and Money Marketeers, both affiliated with New York University. He is listed in all editions of "Who's Who In America" since the 45th edition.
* Affiliated with Whitemarsh Capital Advisors, LLC, Member FINRA/SIPC
Copyright © 2018 Whitemarsh Capital LLC - All Rights Reserved.